CapsoVision
Global medical device innovator that specializes in the fields of capsule endoscopy, medical device, and healthcare.
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
* | N/A | $600k | Post IPO Equity |
| Total Funding | 000k | ||
| USD | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 21 % | 20 % | 90 % | 98 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | (112 %) | (165 %) | - | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | (116 %) | (169 %) | (158 %) | (58 %) | (2 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 96 % | 129 % | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
CapsoVision, Inc. is a medical technology company specializing in capsule endoscopy systems designed to enhance diagnostic accuracy and patient comfort. The company's flagship product, CapsoCam Plus, is a capsule endoscope that captures 360-degree panoramic images of the gastrointestinal tract, providing a comprehensive view for medical professionals. CapsoVision serves healthcare providers, including hospitals and gastroenterology clinics, primarily in the United States and international markets. The company operates in the medical device industry, focusing on gastrointestinal diagnostics. CapsoVision's business model involves the sale of its CapsoCam Plus system and related software, such as CapsoView, which allows for intuitive image review and analysis. Revenue is generated through direct sales, distribution partnerships, and service agreements. The company has established strategic partnerships, such as its U.S. distribution agreement with PENTAX Medical, to expand its market reach and enhance product availability. CapsoVision's innovative approach aims to improve patient outcomes and streamline diagnostic procedures in the field of gastroenterology.
Keywords: capsule endoscopy, gastrointestinal diagnostics, CapsoCam Plus, 360-degree imaging, healthcare providers, medical technology, diagnostic accuracy, patient comfort, CapsoView software, PENTAX Medical partnership.